Showing results (321-330 of 328) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 328 results.
American Heart Journal|August 10, 2016
Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE TrialHarry P Selker, William S Harris, Charles E Rackley, et al.
Circulation|November 8, 2006
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failureHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
Circulation|September 4, 2008
Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathyHelena Tuunanen, Erik Engblom, Alexandru Naum, et al.
Basic Research in Cardiology|May 27, 2008
Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusionBritt N Fuglesteg, Naushaad Suleman, Crina Tiron, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2003
Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibitionBirger Hesse, Christian Meyer, Flemming S Nielsen, et al.
Cardiovascular Therapeutics|September 3, 2011
Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humansMarco Bucci, Ronald Borra, Kjell Någren, et al.
American Heart Journal|March 20, 2012
Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical servicesHarry P Selker, Joni R Beshansky, John L Griffith, et al.
JAMA|March 29, 2012
Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trialHarry P Selker, Joni R Beshansky, Patricia R Sheehan, et al.
Pageof 33